Comparison Overview

Astellas Pharma

VS

Sanofi

Astellas Pharma

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, JP, 103-8411
Last Update: 2026-01-18
View Profile
Between 750 and 799
http://www.astellas.com/

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 12,110
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Sanofi

46 Avenue de la Grande-Armée, Paris, France, FR, 75017
Last Update: 2026-01-23
Between 800 and 849
https://http://www.sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 91,404
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/astellaspharmainc.jpeg
Astellas Pharma
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Astellas Pharma
100%
Compliance Rate
0/4 Standards Verified
Sanofi
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Sanofi in 2026.

Incident History — Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries

Incident History — Sanofi (X = Date, Y = Severity)

Sanofi cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/astellaspharmainc.jpeg
Astellas Pharma
Incidents

No Incident

https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
Incidents

No Incident

FAQ

Sanofi company demonstrates a stronger AI Cybersecurity Score compared to Astellas Pharma company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Sanofi company has disclosed a higher number of cyber incidents compared to Astellas Pharma company.

In the current year, Sanofi company and Astellas Pharma company have not reported any cyber incidents.

Neither Sanofi company nor Astellas Pharma company has reported experiencing a ransomware attack publicly.

Neither Sanofi company nor Astellas Pharma company has reported experiencing a data breach publicly.

Neither Sanofi company nor Astellas Pharma company has reported experiencing targeted cyberattacks publicly.

Neither Astellas Pharma company nor Sanofi company has reported experiencing or disclosing vulnerabilities publicly.

Neither Astellas Pharma nor Sanofi holds any compliance certifications.

Neither company holds any compliance certifications.

Sanofi company has more subsidiaries worldwide compared to Astellas Pharma company.

Sanofi company employs more people globally than Astellas Pharma company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Astellas Pharma nor Sanofi holds SOC 2 Type 1 certification.

Neither Astellas Pharma nor Sanofi holds SOC 2 Type 2 certification.

Neither Astellas Pharma nor Sanofi holds ISO 27001 certification.

Neither Astellas Pharma nor Sanofi holds PCI DSS certification.

Neither Astellas Pharma nor Sanofi holds HIPAA certification.

Neither Astellas Pharma nor Sanofi holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.

Published
Date
2026-01-23
Updated
Date
2026-01-23
Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
References
Description

A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References
Description

A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References
Description

A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.

Published
Date
2026-01-23
Updated
Date
2026-01-23
Risk Information
cvss3
Base: 6.0
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
cvss4
Base: 6.0
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References